NBIX logo

Neurocrine Biosciences (NBIX) Short term debt

Annual short term debt:

N/A
December 31, 2024

Summary

  • NBIX annual short term debt is not available.

Performance

NBIX Short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherNBIXbalance sheet metrics

quarterly short term debt:

N/A
March 31, 2025

Summary

  • NBIX quarterly short term debt is not available.

Performance

NBIX quarterly short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherNBIXbalance sheet metrics

Short term debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

NBIX Short term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

NBIX Short term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

NBIX Short term debt History

DateAnnualQuarterly
Mar 2024
-
$259.00M(+52.3%)
Dec 2023
$170.10M(+0.4%)
$170.10M(-9.4%)
Sep 2023
-
$187.70M(+0.2%)
Jun 2023
-
$187.40M(+10.6%)
Dec 2022
$169.40M(-58.6%)
$169.40M(+0.1%)
Sep 2022
-
$169.20M(-60.2%)
Sep 2020
-
$425.00M(+1.3%)
Jun 2020
-
$419.50M(+2.6%)
Dec 2019
$408.80M(+5094.4%)
$408.80M(+6.6%)
Sep 2018
-
$383.65M(+9379.8%)
Sep 2010
-
$4.05M(-9.1%)
Jun 2010
-
$4.45M(+1.9%)
Mar 2010
-
$4.37M(-50.9%)
Sep 2009
-
$8.90M(-42.3%)
Jun 2009
-
$15.41M(+1.4%)
Mar 2009
-
$15.20M(+93.2%)
Dec 2008
$7.87M(+429.6%)
$7.87M(+2751.4%)
Sep 2008
-
$276.00K(-54.1%)
Jun 2008
-
$601.00K(-41.4%)
Mar 2008
-
$1.02M(-31.0%)
Dec 2007
$1.49M(-66.9%)
$1.49M(-44.8%)
Sep 2007
-
$2.69M(-17.7%)
Jun 2007
-
$3.27M(-15.6%)
Mar 2007
-
$3.88M(-13.6%)
Dec 2006
$4.49M(-22.8%)
$4.49M(-7.7%)
Sep 2006
-
$4.86M(-7.3%)
Jun 2006
-
$5.25M(-5.4%)
Mar 2006
-
$5.55M(-4.6%)
Dec 2005
$5.81M
$5.81M(-3.9%)
DateAnnualQuarterly
Sep 2005
-
$6.05M(-2.9%)
Jun 2005
-
$6.23M(-3.5%)
Mar 2005
-
$6.46M(-3.2%)
Dec 2004
$6.67M(+68.5%)
$6.67M(+40.4%)
Sep 2004
-
$4.75M(+20.4%)
Jun 2004
-
$3.95M(-2.2%)
Mar 2004
-
$4.03M(+1.9%)
Dec 2003
$3.96M(+49.0%)
$3.96M(+15.7%)
Sep 2003
-
$3.42M(+2.3%)
Jun 2003
-
$3.34M(+13.8%)
Mar 2003
-
$2.94M(+10.6%)
Dec 2002
$2.66M(+27.4%)
$2.66M(+19.9%)
Sep 2002
-
$2.22M(+13.3%)
Jun 2002
-
$1.96M(+3.7%)
Mar 2002
-
$1.89M(-9.6%)
Dec 2001
$2.09M(+31.5%)
$2.09M(+23.2%)
Sep 2001
-
$1.69M(-2.7%)
Jun 2001
-
$1.74M(+12.5%)
Mar 2001
-
$1.55M(-2.5%)
Dec 2000
$1.59M(+58.7%)
$1.59M(+38.4%)
Sep 2000
-
$1.15M(+14.0%)
Jun 2000
-
$1.01M(+1.6%)
Mar 2000
-
$990.00K(-1.0%)
Dec 1999
$1.00M(+25.0%)
$1.00M(+11.1%)
Sep 1999
-
$900.00K(-40.0%)
Mar 1999
-
$1.50M(+87.5%)
Dec 1998
$800.00K(-11.1%)
$800.00K(-11.1%)
Dec 1997
$900.00K(+12.5%)
$900.00K(+12.5%)
Dec 1996
$800.00K
$800.00K(0.0%)
Mar 1996
-
$800.00K

FAQ

  • What is the all time high annual short term debt for Neurocrine Biosciences?
  • What is the all time high quarterly short term debt for Neurocrine Biosciences?

What is the all time high annual short term debt for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual short term debt is $408.80M

What is the all time high quarterly short term debt for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly short term debt is $425.00M
On this page